| abstract |
Disclosed are compounds that are effective in blocking the replication of hepatitis C virus (“HCV”) or other viruses. The present invention relates to compositions comprising such compounds, co-formulation or co-administration of such compounds with other antiviral or therapeutic agents, methods and intermediates for synthesizing such compounds, and HCV infections or other viruses. Also contemplated are methods of using the compounds for treating infections. |